Stay updated with breaking news from Intervention Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A study of two widely used cardiovascular medications — cilostazol and isosorbide mononitrate — in more than 350 patients confirmed the two medications were well-tolerated and safe for people who have experienced a stroke in a small blood vessel deep in the brain.
A preliminary study of two common cardiovascular medications, cilostazol and isosorbide mononitrate, suggests these two medications were safe and well-tolerated by adults who have experienced small vessel stroke, when taken alone or together
Press release content from Business Wire. The AP news staff was not involved in its creation. PhaseBio Reports Fourth-Quarter and Full-Year 2020 Financial Results and Recent Business Highlights March 15, 2021 GMT MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--Mar 15, 2021-- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today reported financial results for the fourth-quarter and full-year ended December 31, 2020 and provided an update on clinical trial activ...